The new screening test is for pre-eclampsia, a complication during pregnancy (Image: Pixabay) Pre-eclampsia affects up to ...

Altris AI, which offers OCT analysis for retinal diseases, is now expanding to glaucoma detection.With its optic disc ...

Whether you need to scan family photos, piles of documents, or expense receipts, a scanner out there is built for the task. Here's how to shop for the right one, plus the top performers in our lab ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. The best OBD-II scanners can unlock the secrets of your car, connecting to the onboard ...

Whatever you might say about them, they’ve never been ones to do things by halves. Now, Kyle & Jackie O are preparing to hold their first outside broadcast in Melbourne since their KIIS FM show was ...

Here are two no-brainer healthcare stocks to buy with $500 right now. Vertex Pharmaceuticals Inc. gained 1.740% today. The stock is an absolute favorite of our community with 57 Buy predictions and no ...

To that end, Florida Tech has relaunched the underutilized Center for Advanced Manufacturing and Innovative Design as Vertex, a new "applied innovation hub." Rather than function as a traditional ...

Vertex Machineries Limited (VML) was incorporated as a Private Limited Company on 12th September 1994 under the companies Act, 1956 and converted into a public Limited Company by passing a special ...

Lati­go Bio­ther­a­peu­tics, a non-opi­oid pain biotech look­ing to ride the waves cre­at­ed by Ver­tex Phar­ma­ceu­ti­cals’ pain drug ap­proval last month, is tar­get­ing up to … ...

At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown its team year-over-year. At a time when many life sciences companies are ...

A CT scan uses numerous X-rays to capture a cross-section of your body. It can detect soft tissues and blood vessels. A computer then uses the X-rays to create a three-dimensional image of your ...

AlgoTx’s mid-stage stumble on Tuesday comes after Vertex earlier this month won the FDA’s approval for Journavx, an inhibitor of the NaV1.8 voltage-gated sodium channel that marks the first new ...